J&J COVID Shot 73.6% Effective in Real-World Study

(MedPage Today) -- Real-world effectiveness with Johnson & Johnson's (J&J) adenoviral vector COVID-19 vaccine (Ad26.COV) tracked closely with the clinical trial data in terms of preventing infections and severe outcomes, a retrospective...